Derma Sciences to Present at the Jefferies 2011 Global Healthcare Conference
September 26 2011 - 9:17AM
Business Wire
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and
pharmaceutical company focused on advanced wound care announced
today that the Company will be presenting at the Jefferies 2011
Global Healthcare Conference on Tuesday, September 27, 2011 at 5:00
p.m. BST (Noon EDT). The conference is being held September 27-28,
2011 at the Waldorf Hilton Hotel in London, United Kingdom. Edward
J. Quilty, Chairman and CEO, will deliver the Company's corporate
presentation.
The presentation will be webcast live at
http://wsw.com/webcast/jeff62/dsci/ and on the Investor Relations
section of the Company's website at www.dermasciences.com, where it
will also be archived for 90 days.
Derma Sciences is a medical technology company focused on the
wound care marketplace, addressing; traditional dressings, advanced
wound care dressings, and pharmaceutical wound care products. Its
MEDIHONEY product is the leading brand of honey-based dressings for
the management of wounds and burns. The product has been shown to
be effective in a variety of indications, and was the focus of a
positive large-scale, randomized controlled trial involving 108
subjects with leg ulcers. Other novel products introduced into the
$14 billion global wound care market include XTRASORB for better
management of wound exudate, and BIOGUARD for infection prevention.
Derma Sciences has successfully completed a Phase 2 clinical trial
in diabetic foot ulcer healing with DSC127, a novel pharmaceutical
drug under development for accelerated wound healing and scar
reduction.
For more information please visit www.dermasciences.com.
Derma Sciences, Inc. (NASDAQ:DSCI)
Historical Stock Chart
From Apr 2024 to May 2024
Derma Sciences, Inc. (NASDAQ:DSCI)
Historical Stock Chart
From May 2023 to May 2024